The role of iron in the immune response to bacterial infection

Immunologic Research

Volumn 50, Issue 1, 2011, Pages 1-9

  Cherayil, Bobby J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Infection; Inflammation; Iron metabolism; Macrophage; Siderophore

Indexed keywords

CD71 ANTIGEN; CYTOKINE; FERROPORTIN; HEMOGLOBIN; HEPCIDIN; HFE PROTEIN; INTERLEUKIN 6; IRON; IRON REGULATORY FACTOR; LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TOLL LIKE RECEPTOR 4; TRANSFERRIN RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIMICROBIAL ACTIVITY; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; CYTOKINE PRODUCTION; ENTERITIS; ERYTHROCYTE; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON RESPONSIVE ELEMENT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BACTERIAL INFECTIONS; CATION TRANSPORT PROTEINS; COMMUNICABLE DISEASES; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; IMMUNITY; INFLAMMATION; INTRACELLULAR SPACE; IRON;

EID: 79955603039     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-010-8199-1     Document Type: Review

References (91)

1. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001;131:568S-80S.
2. Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112:219-30.
3. Hentze MW, Muckenthaler MU, Galy B, et al. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142:24-38.
4. Biggs TE, Baker ST, Botham MS, et al. Nramp1 modulates iron homeostasis in vivo and in vitro: evidence for a role in cellular iron release involving de-acidification of intracellular vesicles. Eur J Immunol. 2001;31:2060-70. (Pubitemid 32640722)
5. Soe-Lin S, Sheftel AD, Wasyluk B, et al. Nramp1 equips macrophages for efficient iron recycling. Exp Hematol. 2008;36:929-37.
6. Soe-Lin S, Apte SS, Andriopoulos B Jr, et al. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc Natl Acad Sci USA. 2009;106:5960-5.
7. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408. (Pubitemid 26256612)
8. Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalin iron sensing. J Biol Chem. 2006;281:28494-8. (Pubitemid 44506991)
9. Schmidt PJ, Toran PT, Giannetti AM, et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008;7:205-14. (Pubitemid 351285524)
10. Gao J, Chen J, Kramer M, et al. Interaction of the hereditary hemochromatosis protein, HFE, with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009;9:217-27.
11. Andriopoulos B, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009;41:482-7.
12. Meynard D, Kautz L, Darnaud V, et al. Lack of BMP6 induces massive iron overload. Nat Genet. 2009;41:478-81.
13. Ganz T, Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med. 2011;62:13.1-4. (epub ahead of print).
14. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-3. (Pubitemid 40007660)
15. De Domenico I, Ward DM, Langelier C, et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 2007;18:2569-78. (Pubitemid 47025722)
16. De Domenico I, Lo E, Ward DM, et al. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc Natl Acad Sci USA. 2009;106:3800-5.
17. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-6. (Pubitemid 39069926)
18. Lee P, Peng H, Gelbart T, Beutler E. The IL-6 and LPS-induced transcription of hepcidin in Hfe- TfR2- and β2-microglobulin-deficient mice. Proc Natl Acad Sci USA. 2004;101:9263-5.
19. Lee P, Peng H, Gelbart T, et al. Regulation of hepcidin transcription by IL-1 and IL-6. Proc Natl Acad Sci USA. 2005;102:1906-10. (Pubitemid 40261985)
20. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008;28:197-213.
21. Wang L, Cherayil BJ. Ironing out the wrinkles in host defense: interactions between iron homeostasis and innate immunity. J Innate Immun. 2009;1:455-64.
22. Forbes JR, Gros P. Divalent metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 2001;9:397-403.
23. Cellier MF, Courville P, Campion C. Nramp1 phagocyte intracellular metal withdrawal defense. Microbes Infect. 2007;9:1662-70. (Pubitemid 350225742)
24. Moller M, Hoal EG. Current findings, challenges and novel approaches to human genetic susceptibility to tuberculosis. Tuberculosis (Edinb). 2010;90:71-83.
25. Chlosta S, Fishman DS, Harrington L, et al. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect Immun. 2006;74:3065-7. (Pubitemid 43673024)
26. Olakanmi O, Schlesinger LS, Britigan BE. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J Leukoc Biol. 2007;81:195-204. (Pubitemid 46021269)
27. Nairz M, Theurl I, Ludwiczek S, et al. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 2007;9:2126-40. (Pubitemid 47250286)
28. Paradkar PN, De Domenico I, Durchfort N, et al. Iron depletion limits intracellular bacterial growth in macrophages. Blood. 2008;112:866-74.
29. Nairz M, Fritsche G, Brunner P, et al. Interferon γ limits the availability of iron for intra-macrophage Salmonella typhimurium. Eur J Immunol. 2008;38:1923-36.
30. Peyssonaux C, Zinkernagel AS, Datta V, et al. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107:3727-32.
31. Nguyen NB, Callaghan KD, Ghio AJ, et al. Hepcidin expression and iron transport in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2006;291:L417-25.
32. Theurl I, Theurl M, Seifert M, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood. 2008;111:2392-9. (Pubitemid 351451452)
33. Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol. 2004;2:946-53. (Pubitemid 39562533)
34. Doherty CP. Host-pathogen interactions: the role of iron. J Nutr. 2007;137:1341-4. (Pubitemid 46701932)
35. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010;139:393-408.
36. Zhou XY, Tomatsu S, Fleming RE, et al. Hfe gene knock-out produces a mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA. 1998;95:2492-7. (Pubitemid 28145969)
37. Wang L, Johnson EE, Shi HN, et al. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J Immunol. 2008;181:2723-31.
38. Gomes-Pereira S, Rodrigues PN, Appelberg R, et al. Increased susceptibility to Mycobacterium avium in hemochromatosis protein Hfe-deficient mice. Infect Immun. 2008;76:4713-9.
39. Johnson EE, Sandgren A, Cherayil BJ, et al. Role of ferroportin in macrophage-mediated immunity. Infect Immun. 2010;78:5099-106.
40. Wang L, Harrington L, Trebicka E, et al. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest. 2009;119:3322-8.
41. Sheedy FJ, O'Neill LA. The Troll in Toll: Mal and TRAM as bridges for TLR2 and TLR4 signaling. J Leukoc Biol. 2007;82:196-203. (Pubitemid 47230627)
42. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373-84.
43. Kagan JC, Su T, Horng T, et al. TRAM couples endocytosis of TLR4 to the induction of interferon-beta. Nat Immunol. 2008;9:361-8. (Pubitemid 351405105)
44. Nairz M, Theurl I, Schroll A, et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood. 2009;114: 3642-51.
45. Levy JE, Montross LK, Cohen DE, et al. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood. 1999;94:9-11. (Pubitemid 29300128)
46. Bahram S, Gilfillan S, Kuhn LC, et al. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc Natl Acad Sci USA. 1999;96:13312-7.
47. De Domenico I, Zhang TY, Branch LW, et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest. 2010;120:2395-405.
48. Bullen JJ, Spalding PB, Ward CG, et al. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med. 1991;151:1606-9.
49. Bergmann TK, Vinding K, Hey H. Multiple hepatic abscesses due to Yersinia enterocolitica infection secondary to primary hemochromatosis. Scand J Gastroenterol. 2001;36:891-5. (Pubitemid 32656567)
50. WrightAC, SimpsonLM,Oliver JD. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun. 1981;34:503-7.
51. Gordeuk VR, Ballou S, Lozanski G, et al. Decreased concentrations of TNFα in supernatants of monocytes from homozygotes for hereditary hemochromatosis. Blood. 1992;79:1855-60.
52. Gordeuk VR, Caleffi A, Corradini E, et al. Iron overload in Africans and African-Americans and a common mutation in the SLC40A1 (ferroportin 1) gene. Blood Cells Mol Dis. 2003;31:299-304. (Pubitemid 37433868)
53. Beutler E, Barton JC, Felitti VJ, et al. Ferroportin 1 (SLC40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis. 2003;31:305-9. (Pubitemid 37441302)
54. McNamara L, Gordeuk VR, MacPhail AP. Ferroportin (Q248H) mutations in African families with dietary iron overload. J Gastroenterol Hepatol. 2005;20:1855-8. (Pubitemid 43961041)
55. Boelaert JR, Vandecasteele SJ, Appelberg R, et al. The effect of the host's iron status on tuberculosis. J Infect Dis. 2007;195:1745-53. (Pubitemid 46870246)
56. Gomolion F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol. 2009;15:4659-65.
57. Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7:599-610.
58. Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Semin Hematol. 2009;46:387-93.
59. Wessling-Resnick M. Iron homeostasis and the inflammatory response. Annu Rev Nutr. 2010;30:105-22.
60. Semrin G, Fishman DS, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis. 2006;12:1101-6. (Pubitemid 44847466)
61. Cherayil BJ. Cross-talk between iron homeostasis and intestinal inflammation. Gut Microbes. 2010;1:65-9.
62. Babitt JL, Huang FW, Xia Y, et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest. 2007;117:1933-9. (Pubitemid 47036327)
63. Yu PB, Hong CC, Sachidanandan C, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2008;4:33-41. (Pubitemid 350273653)
64. Berg DJ, Zhang J, Weinstock JV, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology. 2002;123:1527-42.
65. Legrand D, Mazurier J. A critical review of the roles of host lactoferrin in immunity. Biometals. 2010;23:365-76.
66. Ward PP, Mendoza-Meneses M, Park PW, et al. Stimulus-dependent impairment of neutrophil oxidative burst response in lactoferrin-deficient mice. Am J Pathol. 2008;172:1019-29. (Pubitemid 351519998)
67. Clifton MC, Corrent C, Strong RK. Siderocalins: siderophore-binding proteins of the innate immune system. Biometals. 2009;22:557-64.
68. Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with side-rophore-mediated iron acquisition. Mol Cell. 2002;10:1033-43. (Pubitemid 36001971)
69. Miethke M, Marahiel MA. Siderophore-based iron acquisition and pathogen contol. Microbiol Mol Biol Rev. 2007;71:413-51. (Pubitemid 47429279)
70. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432:917-21. (Pubitemid 40037155)
71. Berger T, Togawa A, Duncan GS, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA. 2006;103:1834-9. (Pubitemid 43228779)
72. Chan YR, Liu JS, Pociask DA, et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol. 2009;182:4947-56.
73. Fischbach MA, Lin H, Liu DR, et al. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol. 2006;2:132-8. (Pubitemid 44323863)
74. Fischbach MA, Lin H, Zhou L, et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA. 2006;103:16502-7. (Pubitemid 44715225)
75. Raffatellu M, George MD, Akiyama Y, et al. Lipocalin 2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe. 2009;5:476-86.
76. Holmes MA, Paulsene W, Jide X, et al. Siderocalin (Lcn2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure. 2005;13:29-41. (Pubitemid 40092472)
77. Saiga H, Nishimura J, Kuwata H, et al. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol. 2008;181:8521-7.
78. Johnson EE, Srikanth CV, Sandgren A, et al. Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages. FEMS Immunol Med Microbiol. 2010;58:138-45.
79. Martineau AR, Newton SM, Wilkinson KA, et al. Neutrophil-mediated innate immune resistance to mycbacteria. J Clin Invest. 2007;117:1988-94. (Pubitemid 47036333)
80. Landro L, Damas JK, Flo TH, et al. Decreased serum lipocalin 2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy. Clin Exp Immunol. 2008;152:57-63. (Pubitemid 351347544)
81. Devireddy LR, Hart DO, Goetz DH, et al. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell. 2010;141:1006-17.
82. Bao G, Clifton M, Hoette TM, et al. Iron traffics in circulation bound to a siderocalin (NGAL)-catechol complex. Nat Chem Biol. 2010;6:602-9.
83. Philpott C. Bioinorganic chemistry: getting a grip on iron. Nat Chem Biol. 2010;6:568-70.
84. Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by lipocalin. Mol Cell. 2002;10:1045-56. (Pubitemid 35453824)
85. Kaplan J. Mechanisms of cellular iron acquisition: another iron in the fire. Cell. 2002;111:603-6. (Pubitemid 35441241)
86. Devireddy LR, Gazin C, Zhu X, et al. A cell surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell. 2005;123:1293-305. (Pubitemid 41821786)
87. Richardson DR. 24p3 and its receptor: dawn of a new iron age? Cell. 2005;123:1175-7.
88. Breuer W, Shvartsman M. Cabantchik ZI: Intracellular labile iron. Int J Biochem Cell Biol. 2008;40:350-4. (Pubitemid 351241220)
89. Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular, other progressive inflammatory, degenerative diseases. BMC Med Genomics. 2009;2:2.
90. Kell DB. Towards a unifying systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch Toxicol. 2010;84:825-89.
91. Baker M, Wilson D, Sabeti PC, et al. Host genetic factors involved in iron regulation may influence susceptibility to Mycobacterium tuberculosis: a pilot study. Abstract presented at the Fourth Annual New England TB Symposium, July 2010.